Maher A - Search Results

1

Omalizumab Transitions in Severe Asthma: Factors Influencing Switching Decisions and Timing for Optimal Response.

Al-Ahmad M, Ali A, Maher A. Al-Ahmad M, et al. Among authors: maher a. Med Princ Pract. 2023;32(6):323-331. doi: 10.1159/000534319. Epub 2023 Sep 27. Med Princ Pract. 2023. PMID: 37757780 Free PMC article.

2

"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma.

Al-Ahmad M, Arifhodzic N, Nurkic J, Maher A, Rodriguez-Bouza T, Al-Ahmed N, Sadek A, Jusufovic E. Al-Ahmad M, et al. Among authors: maher a. Med Princ Pract. 2018;27(3):260-266. doi: 10.1159/000487482. Epub 2018 Feb 7. Med Princ Pract. 2018. PMID: 29414831 Free PMC article.

3

Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up.

Al-Ahmad M, Nurkic J, Maher A, Arifhodzic N, Jusufovic E. Al-Ahmad M, et al. Among authors: maher a. Open Access Maced J Med Sci. 2018 Oct 18;6(10):1839-1844. doi: 10.3889/oamjms.2018.394. eCollection 2018 Oct 25. Open Access Maced J Med Sci. 2018. PMID: 30455759 Free PMC article.

4

Most common, real life factors affecting effectiveness of omalizumab asthma treatment: a 10-year study.

Nurkić J, Al-Ahmad M, Maher A, Arifhodžić N, Jusufović E. Nurkić J, et al. Among authors: maher a. Med Glas (Zenica). 2019 Feb 1;16(1):45-52. doi: 10.17392/972-19. Med Glas (Zenica). 2019. PMID: 30589240 Free article.

5

Severe asthma in Kuwait population: Phenotype-based approach.

Al-Ahmad M, Nurkic J, Othman Y, Jusufovic E, Maher A. Al-Ahmad M, et al. Among authors: maher a. Respir Med. 2021 Oct;187:106586. doi: 10.1016/j.rmed.2021.106586. Epub 2021 Aug 27. Respir Med. 2021. PMID: 34474336 Free article.

6

Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study.

Al-Ahmad M, Ali A, Maher A. Al-Ahmad M, et al. Among authors: maher a. BMC Pulm Med. 2023 Dec 5;23(1):490. doi: 10.1186/s12890-023-02786-w. BMC Pulm Med. 2023. PMID: 38053108 Free PMC article.

7

Association between interleukin-6-174G/C gene polymorphism and asthma severity: exploring the role of total serum IgE, blood eosinophils, and FeNO as markers of type 2 inflammation.

Al-Ahmad M, Ali A, Maher A, Haider MZ. Al-Ahmad M, et al. Among authors: maher a. Allergy Asthma Clin Immunol. 2024 Feb 22;20(1):15. doi: 10.1186/s13223-024-00880-0. Allergy Asthma Clin Immunol. 2024. PMID: 38388670 Free PMC article.

8

Highly Efficient and achromatic mid-infrared silicon nitride meta-lenses.

Maher A, Swillam MA. Maher A, et al. Sci Rep. 2025 Jan 15;15(1):2008. doi: 10.1038/s41598-024-83728-2. Sci Rep. 2025. PMID: 39814740 Free PMC article.

9

Clinical and Dermoscopic Manifestations of Ungual Scabies in an Infant.

Maher AM, Suaad AG. Maher AM, et al. Int J Dermatol. 2025 Jan 13. doi: 10.1111/ijd.17656. Online ahead of print. Int J Dermatol. 2025. PMID: 39803730 No abstract available.

10

Correction: 10-Hydroxy Decanoic Acid and Zinc Oxide Nanoparticles Retrieve Nrf2/HO-1 and Caspase-3/Bax/Bcl-2 Signaling in Lead-Induced Testicular Toxicity.

Maher AM, Elsanosy GA, Ghareeb DA, Elblehi SS, Saleh SR. Maher AM, et al. Biol Trace Elem Res. 2024 Dec 20. doi: 10.1007/s12011-024-04491-z. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 39704956 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters